Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 48, 2012, Pages 19864-19869

  Hu, Yuanxin ^a   Matkovich, Scot J ^a   Hecker, Peter A ^a   Zhang, Yan ^a   Edwards, John R ^a   Dorn II, Gerald W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

microRNA mRNA interactome; Systems biology; Transcriptome regulation

Indexed keywords

MESSENGER RNA; MICRORNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EPIGENETICS; EPITRANSCRIPTIONAL ORCHESTRATION; GENE AMPLIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN PROCESSING; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; MICE; MICRORNAS; MYOCARDIUM; STRESS, PHYSIOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 84870359499     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1214996109     Document Type: Article

References (51)

1. Dorn GW II, Robbins J, Sugden PH (2003) Phenotyping hypertrophy: Eschew obfuscation. Circ Res 92(11):1171-1175.
2. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313(5795):1922-1927.
3. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136(2):215-233.
4. Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469(7330):336-342.
5. van Rooij E, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103(48):18255-18260.
6. Thum T, et al. (2007) MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 116(3):258-267.
7. Matkovich SJ, et al. (2009) Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119(9):1263-1271.
8. Montgomery RL, et al. (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124(14):1537-1547.
9. Matkovich SJ, Van Booven DJ, Eschenbacher WH, Dorn GW II (2011) RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ Res 108 (1):18-26.
10. Matkovich SJ, Zhang Y, Van Booven DJ, Dorn GWII (2010) Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: Application to Galphaq. Circ Res 106(9):1459-1467.
11. Thum T, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980-984.
12. Dong S, et al. (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284(43):29514-29525.
13. Willers IM, Martínez-Reyes I, Martínez-Diez M, Cuezva JM (2012) miR-127-5p targets the 3′UTR of human β-F1-ATPase mRNA and inhibits its translation. Biochim Biophys Acta 1817(5):838-848.
14. da Costa Martins PA, et al. (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12 (12):1220-1227.
15. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5(7):621-628.
16. Dorn GW II (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49(5):962-970.
17. Huss JM, Kelly DP (2005) Mitochondrial energy metabolism in heart failure: A question of balance. J Clin Invest 115(3):547-555.
18. Raddatz K, Albrecht D, Hochgräfe F, Hecker M, Gotthardt M (2008) A proteome map of murine heart and skeletal muscle. Proteomics 8(9):1885-1897.
19. Hamelin M, et al. (2006) Proteomic analysis of ovine muscle hypertrophy. J Anim Sci 84(12):3266-3276.
20. Bupha-Intr T, Holmes JW, Janssen PM (2007) Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium. Am J Physiol Heart Circ Physiol 293(6):H3759-H3767.
21. Patton WF, Erdjument-Bromage H, Marks AR, Tempst P, Taubman MB (1995) Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing. J Biol Chem 270(36):21404-21410.
22. Kang MY, et al. (2010) Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. Circ Res 107(7):903-912.
23. Xiong J, Du Q, Liang Z (2010) Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29(35):4980-4988.
24. Cordes KR, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256):705-710.
25. Elia L, et al. (2009) The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death Differ 16(12):1590-1598.
26. Small EM, et al. (2010) Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 107(9):4218-4223.
27. Tatsuguchi M, et al. (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42(6):1137-1141.
28. Elia L, et al. (2009) Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120(23):2377-2385.
29. Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436(7048):214-220.
30. Chen JF, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38(2):228-233.
31. Zhao Y, et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129(2):303-317.
32. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100(3):416-424.
33. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J 276(8):2348-2358.
34. Wang J, et al. (2012) Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 22(3):516-527.
35. Roy S, et al. (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82(1):21-29.
36. Patrick DM, et al. (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120(11):3912-3916.
37. Saito Y, et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6):435-443.
38. Bhaskaran M, et al. (2009) MicroRNA-127 modulates fetal lung development. Physiol Genomics 37(3):268-278.
39. Song XW, et al. (2010) MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol 225(2):437-443.
40. Ghaemmaghami S, et al. (2003) Global analysis of protein expression in yeast. Nature 425(6959):737-741.
41. Baek D, et al. (2008) The impact of microRNAs on protein output. Nature 455(7209):64-71.
42. Selbach M, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209):58-63.
43. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835-840.
44. Dorn GW II (2012) Decoding the cardiac message: The 2011 Thomas W. Smith Memorial Lecture. Circ Res 110(5):755-763.
45. Lagos-Quintana M, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12(9):735-739.
46. Rao PK, et al. (2009) Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 105(6):585-594.
47. Rau F, et al. (2011) Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 18(7):840-845.
48. Palacín M, et al. (2011) Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations. Clin Chem 57 (11):1614-1616.
49. Resnick M (1994) Turtles, Termites, and Traffic Jams: Explorations in Massively Parallel Microworlds (Complex Adaptive Systems) (MIT Press, Cambridge, MA).
50. Sakata Y, Hoit BD, Liggett SB, Walsh RA, Dorn GW II (1998) Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation 97(15):1488-1495.
51. Diwan A, et al. (2008) Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 117(3):396-404.